[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Badger et al., 1981 - Google Patents

Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity

Badger et al., 1981

Document ID
12743649072460000508
Author
Badger A
Oh S
Moolten F
Publication year
Publication venue
Cancer Research

External Links

Snippet

The ascites fluids from humans with cancer that has metastasized to the peritoneum is suppressive of the immune response both in vitro and in vivo. The active moiety is present in a high-molecular-weight fraction which elutes in the void volume of a Sephadex G-200 …
Continue reading at aacrjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Opelz et al. Autologous stimulation of human lymphocyte subpopulations
Mellstedt In vitro activation of human T and B lymphocytes by pokeweed mitogen.
Wakasugi et al. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432
Santoli et al. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
Vogel et al. Differential modulation of macrophage membrane markers by interferon: analysis of Fc and C3b receptors, Mac-1 and Ia antigen expression
Badger et al. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity
Craddock et al. Circulating stem cells in mice treated with cyclophosphamide
Han et al. In vitro functional studies of mononuclear cells in patients with CLL. Evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes
Carlsson et al. Histamine modulates the production of interferon-γ and interleukin-2 by mitogen-activated human mononuclear blood cells
Golub et al. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity
Ebert et al. Selective immunosuppressive action of a factor produced by colon cancer cells
Vaickus et al. Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis
Bean et al. Occurrence of restricted suppressor T-cell activity in man.
Haagen et al. The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2
Oshimi et al. Lysis of leukemia and lymphoma cells by autologous and allogeneic interferon-activated blood mononuclear cells
Ćemerlíc et al. Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes
ORTALDO et al. Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells
Nair et al. Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes.
Oshima et al. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
Ortaldo et al. Cytotoxicity from cultured cells: Analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity
Tarkkanen et al. Suppressor cells of natural killer activity in normal and tumor-bearing individuals
Duhrsen et al. Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia
Shitara et al. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Biddle et al. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors
Moore et al. Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes